A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma

Published:2003-07 Issue:11 Volume:17 Page:F17-F22
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Portsmouth Simon,Stebbing Justin,Gill Jas,Mandalia Sundhiya,Bower Mark,Nelson Mark,Bower Mark,Gazzard Brian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference27 articles.

1. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy

2. Incidence of acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma in the Aquitaine Cohort, France, 1988-1996. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine

3. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi‚s sarcoma

4. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposiʼs sarcoma

5. TIMING OF ANTIBODIES TO HUMAN HERPESVIRUS-8 (HHV-8) AMONG HIV-1 SEROCONVERTERS AND PROGRESSION TO KAPOSI'S SARCOMA

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIs versus NNRTIs and the Risk of Cancer among People with HIV;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-04-23

2. Kaposi Sarcoma;Rook's Textbook of Dermatology;2024-03-19

3. The role of transposable elements in aging and cancer;Biogerontology;2023-04-05

4. Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition;Cancers;2021-11-15

5. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy;HIV Medicine;2021-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3